RZRuqsar Zaitoon

Ruqsar Zaitoon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruqsar Zaitoon has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Minimum Redundancy Maximum Relevance Enhanced Binary Zebra Optimization for Cancer Prediction

    by Bibhuprasad Sahu, Amrutanshu Panigrahi, Abhilash Pati, Ruqsar Zaitoon, Ramakanta Behera, Janmejaya Mishra

    The presence of redundant and nois features in the microarray datasets deteriorates the performance of the classification algorithm. Removal of such features is a really challenging task for all researchers. This criticism encourages all to develop different feature selection (FS) models. FS plays a key role in selecting the pertinent features from the high-dimensional datasets by reducing the dimensionality. This study proposed a minimum redundant maximum relevance (mRMR) enhanced binary zebra optimization (BZO) for the cancer prediction model. The proposed filter-wrapper model is divided into two phases. In the filter phase, MRmMC is implemented to select K highrank features by eliminating low-rank features according to the threshold value. In the wrapper phase, a novel binary version of Zebra optimizer with kNN classifier is used to select the optimal feature subset. The Support Vector Machine (SVM), Naive Bayes (NB), and Random Forest (RF) are three prominent classifiers that are used to understand the efficacy. Six performance metrics and five cancer datasets are adopted to carry out the experimental analysis. According to the result achieved, the proposed algorithm achieves 98.98%, 95.12%, 97.18% for breast cancer, ALL-AML, Ovarian dataset with NB classifier. Similarly, it performs with an accuracy of 96.51% and 96.81% for Colon and CNS datasets with the SVM classifier.


  • Open Access

    SPBTGNS: Design of an Efficient Model for Survival Prediction in Brain Tumour Patients Using Generative Adversarial Network With Neural Architectural Search Operations

    by Ruqsar Zaitoon, Sachi Nandan Mohanty, Deepthi Godavarthi, Janjhyam Venkata Naga Ramesh

    The landscape of medical imaging, particularly in brain tumor analysis and survival prediction, necessitates advancements due to the inherent complexities and life-threatening nature of brain tumors. Existing methodologies often struggle with precision and efficiency, predominantly due to limitations in handling the diverse and intricate nature of medical image datasets. This research presents a novel approach that aims to improve the accuracy of survival prediction in patients with brain tumours, leveraging a Generative Adversarial Network (GAN) integrated with Neural Architectural Search (NAS) operations. The model employs the Adaptive Computation Time (ACT) Transformer, a method crucial for dynamically adjusting the number of transformer layers based on the complexity of the input sets. This feature is particularly beneficial in medical imaging for adapting to the varying complexities of brain tumor data samples. The integration of Squeeze-and-Excitation Networks (SENet) enables the model to recalibrate features channel-wise, significantly enhancing sensitivity to pivotal features in MRI images. Furthermore, the application of Google’s AutoML Vision Edge offers efficient neural architecture and hyperparameter optimization, specifically tuned for image data samples. Efficient Neural Architecture Search (ENAS) is utilized to discover high-performance models with lower computational demands, a critical aspect for medical image analysis where resource constraints are common for different use cases. The model also incorporates customized loss functions, particularly Weighted Cross-Entropy Loss, addressing the class imbalance in medical datasets by emphasizing rarer tumor types. Spatial Dropout and Batch Normalization are integrated as regularization techniques to improve generalization and reduce overfitting risks. The model’s efficacy was validated on the Br35H, Kaggle Brain Tumor Dataset, and IEEE Data Port Dataset Databases, exhibiting a notable improvement over existing methods: 5.9% better precision, 6.5% higher accuracy, and 4.9% higher recall in brain tumor analysis. In survival analysis, the model demonstrated 8.5% better precision and 8.3% higher accuracy, among other improvements. These enhancements underscore the model’s capability in providing more accurate, efficient, and reliable predictions for brain tumor patients, potentially revolutionizing the approach to brain tumor diagnosis and survival prognostication in clinical settings.


  • Open Access

    RU-Net2+: A Deep Learning Algorithm for Accurate Brain Tumor Segmentation and Survival Rate Prediction

    by Ruqsar Zaitoon, Hussain Syed

    Brain tumors present a significant medical concern, posing challenges in both diagnosis and treatment. Deep learning has emerged as an evolving technique for automating the diagnostic process for brain tumors. This research paper introduces a novel deep-learning framework designed explicitly for brain tumor diagnosis. The framework encompasses various tasks: tumor detection, classification, segmentation, and survival rate prediction. The framework was applied to the BraTS dataset, an extensive collection of brain tumor images, to evaluate its effectiveness. The proposed workflow initiates with data acquisition, followed by an enhancement of this data using a Convolutional Normalized Mean Filter (CNMF) during pre-processing. This prepares the data for the multi-class classification performed using the novel DBT-CNN classifier model. For precise tumor demarcation, the RU-Net2+ model is employed, yielding segmented regions from which features are subsequently extracted utilizing the Cox model. These extracted features play a pivotal role in the final step, where the survival rate of patients is predicted using a logistic regression model. The experimental results showcased the exceptional performance of the proposed framework, surpassing current benchmarks in classification accuracy, tumor segmentation precision, and survival rate prediction. For high-grade glioma (HGG) tumors, the framework achieved an impressive classification accuracy of 99.51%, while for low-grade glioma (LGG) tumors, the accuracy reached 99.28%. The accuracy of tumor segmentation stood at 98.39% for HGG tumors and 99.1% for LGG tumors. The RU-Net2+ algorithm accurately predict patient survival rates: 85.71% long-term, 72.72% medium-term, and 61.54% short-term, corresponding Mean Squared Errors of 0.13, 0.21, and 0.31. These results provide valuable insights for medical professionals making brain tumor treatment decisions. Additionally, the framework shows promise for automating brain tumor diagnosis and enhancing patient care.